Is Panton–Valentine leucocidin (PVL) toxin associated with poor clinical outcomes in patients with community-acquired Staphylococcus aureus bacteraemia?
Journal of Medical Microbiology · 2023
DOI: 10.1099/jmm.0.001683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Emma McGuire und 9 weiteren Autor:innen. Beteiligte Einrichtung: HCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency (UKHSA), 1 Colindale Avenue, London, NW9 5EQ, UK. Hauptthemen laut MEDLINE: Staphylococcal Infections, Bacteremia, Methicillin-Resistant Staphylococcus aureus, Community-Acquired Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Panton–Valentine leucocidin (PVL) toxin is a potential determinant of virulence associated with S. aureus infection. Gap Statement. The contribution of PVL to S. aureus pathogenicity remains unclear.
Aim
To compare clinical outcomes in hospitalized patients with PVL-positive and PVL-negative community-acquired (CA) S. aureus bacteraemia.
Methods
Three national datasets were combined to provide clinical and mortality data for patients with CA S. aureus blood culture isolates sent to the UK reference laboratory for PVL testing, August 2018 to August 2021. Multivariable logistic regression models were built for the effect of PVL positivity on 30 day all-cause mortality and 90 day readmission.
Results
In 2191 cases of CA S. aureus bacteraemia, there was no association between PVL and mortality (adjusted odds ratio, aOR: 0·90, 95 % confidence interval, CI: 0·50–1·35, P =0·602) and no difference in median LOS (14 versus 15 days, P =0.169). PVL-positive cases had lower odds of readmission (aOR 0·74, CI 0·55–0.98, P =0·038). There was no evidence that MRSA status modified this effect ( P =0·207).
Conclusions
In patients with CA S. aureus bacteraemia PVL toxin detection was not associated with worse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HCAI, Fungal, AMR, AMU & Sepsis Division, United Kingdom Health Security Agency (UKHSA), 1 Colindale Avenue, London, NW9 5EQ, UK.
- University of Bristol, Beacon House, Queens Road, Bristol, BS8 1QU, UK.
Zitieren
APA
McGuire, E., Neill, C., Collin, S. M., Higgins, H., Guy, R., Ganner, M., Coelho, J., Pichon, B., Hope, R., & Brown, C. S. (2023). Is Panton–Valentine leucocidin (PVL) toxin associated with poor clinical outcomes in patients with community-acquired Staphylococcus aureus bacteraemia?. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001683
Vancouver
McGuire E, Neill C, Collin SM, Higgins H, Guy R, Ganner M, et al. Is Panton–Valentine leucocidin (PVL) toxin associated with poor clinical outcomes in patients with community-acquired Staphylococcus aureus bacteraemia?. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001683
BibTeX
@article{McGuire2023,
author = {McGuire, Emma and Neill, Claire and Collin, Simon M and Higgins, Hannah and Guy, Rebecca and Ganner, Mark and Coelho, Juliana and Pichon, Bruno and Hope, Russell and Brown, Colin S},
title = {Is Panton–Valentine leucocidin (PVL) toxin associated with poor clinical outcomes in patients with community-acquired Staphylococcus aureus bacteraemia?},
journal = {Journal of Medical Microbiology},
year = {2023},
doi = {10.1099/jmm.0.001683}
}
EUVIMED